Invest and Sell Pivot Bio Stock

Pivot Bio stock price

Forge Price ¹

Price not yet available

Last Closed Trade ²

Close Date

xx/xx/xx

Last Closed Trade Price

$xx.xx

Last Funding Round (LFR)

Date

xx/xx/xx

Price per Share

$xx.xx

Access Stock Price

Pivot Bio funding rounds and valuation

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	07/23/2024	Series E	$150MM	$xx.xx	$1.57B	Undisclosed Investors
Price per Share $xx.xx Shares Outstanding 26,302,263 Liquidation Pref Order 1 Liquidation Pref As Multiplier 2.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Undisclosed Investors
	07/19/2021	Series D	$434.54MM	$xx.xx	$1.7B	Dcvc, G2vp, Generation Investment Management, Pavilion Capital, Prelude Ventures, Rockefeller Capital Management, Roger Underwood, Tekfen Ventures, Temasek Holdings
Price per Share $xx.xx Shares Outstanding 57,270,060 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.5x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Dcvc, G2vp, Generation Investment Management, Pavilion Capital, Prelude Ventures, Rockefeller Capital Management, Roger Underwood, Tekfen Ventures, Temasek Holdings
	04/30/2020	Series C	$105MM	$xx.xx	$495.12MM	Alan Cohen, Breakthrough Energy Ventures, Bunge Ventures, Codon Capital, Continental Grain Company, Dcvc, Pavilion Capital, Prelude Ventures, Roger Underwood, Spruce Capital Partners, Tefken Ventures, Temasek
Price per Share $xx.xx Shares Outstanding 36,107,200 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Alan Cohen, Breakthrough Energy Ventures, Bunge Ventures, Codon Capital, Continental Grain Company, Dcvc, Pavilion Capital, Prelude Ventures, Roger Underwood, Spruce Capital Partners, Tefken Ventures, Temasek
	10/02/2018	Series B	$71.33MM	$xx.xx	$210.81MM	Breakthrough Energy Ventures, Teken Ventures, Temasek
Price per Share $xx.xx Shares Outstanding 37,248,430 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Breakthrough Energy Ventures, Teken Ventures, Temasek
	01/13/2016	Series A	$16MM	$xx.xx	$30.77MM	Bill & Melinda Gates Foundation, Dcvc, Genoa Ventures, Monsanto Growth Ventures, Os Fund
Price per Share $xx.xx Shares Outstanding 24,955,520 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Bill & Melinda Gates Foundation, Dcvc, Genoa Ventures, Monsanto Growth Ventures, Os Fund
	10/01/2014	Series Seed	$999,996.40	$xx.xx	$1.67MM	Dcvc, Monsanto Growth Ventures
Price per Share $xx.xx Shares Outstanding 3,846,140 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Dcvc, Monsanto Growth Ventures

Access Stock Price

Pivot Bio stock FAQs

To buy and sell Pivot Bio stock

Can you buy Pivot Bio stock?

As Pivot Bio is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Pivot Bio, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy Pivot Bio stock?

To invest in a private company like Pivot Bio through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Pivot Bio stock?

Yes, you may sell the Pivot Bio stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Pivot Bio stock?

If you hold private company shares of Pivot Bio – whether as an employee or an early investor – Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Pivot Bio on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

To learn more about Pivot Bio stock

Is Pivot Bio a public company?

No, Pivot Bio is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Pivot Bio’s stock price?

Pivot Bio is a privately held company and therefore does not have a public stock price. However, you may access Pivot Bio private market stock price with Forge Data.

What is Pivot Bio’s stock ticker symbol?

Pivot Bio does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Leadership and board

Leadership

Karsten Temme

Chief Executive Officer

Alvin Tamsir

Chief Scientific Officer

Lisa Nunez Safarian

Chief Operating Officer

Doug Jeffries

Chief Financial Officer

John Walls

Chief Information Officer

Devang Shah

General Counsel

Evan Wittenberg

Chief People Officer

Board

Chris Abbott

Continental Grain Company

Susan Kim

PacBio

Monica McGurk

Tropicana and Mainstream Brands

Matt Ocko

DCVC (Data Collective)

Ryan Rakestraw

Temasek

Cooper Rinzler, Ph.D.

Breakthrough Energy

Pivot Bio news and media highlights

SeedWorld 09/05/2023

Pivot Bio names Chris Abbott CEO; announces expansion of U.S. operations

Pivot Bio, Inc., known for delivering sustainability-focused crop nutrition, has named Chris Abbott its Chief Executive Officer effective immediately, according to a press release from the company. Already announced, Pivot Bio co-founder and current CEO Karsten Temme is stepping into the Chief Innovation Officer role.

AgFunderNews 08/29/2023

BREAKING: Bio-input startup Pivot Bio blazes past $100m revenue mark, appoints a new CEO

Nitrogen innovator Pivot Bio‘s revenue hit a milestone by surpassing the $100 million mark, the company reports in its FY2023 results.

New Scientist 06/21/2023

Nitrogen-producing bacteria slash fertiliser use on farms

Pivot Bio, a US-based company, has developed two bacteria-based treatments that can replace about a quarter of the synthetic nitrogen used in fertilisers without affecting crop yield. The treatments, which can be applied directly to the soil or as a coating on seeds, are now being used on over 3 million acres of farmland in the US. The company estimates that this has resulted in a reduction in greenhouse gas emissions equivalent to 220,000 tonnes of CO2.

Yahoo Finance 06/21/2023

Pivot Bio: New Data Shows Potential of Agriculture’s Most Promising Climate Breakthrough

Pivot Bio, a sustainable agriculture company, has released data showing its products helped farmers avoid approximately 226,400 metric tons of carbon emissions in 2022, equivalent to powering 44,000 U.S. homes for a year. The company's products also replaced over 32,000 tons of synthetic fertilizer, delivering greater ROI and higher margins for farmers. The data suggests that Pivot Bio's technology is enabling farmers to improve productivity and profitability without contributing to climate change.

Other companies like Pivot Bio in the Agtech sector

Sector: Foodtech

Subsector: Agtech

					Last Funding Round
Company		Forge Price	Forge Price Change ⁵	Last Closed Trade	Share Class	Post-Money Valuation	Price per Share	Amount Raised
	Apeel	$1.84	-47.28%	$xx.xx	Series E	$2.37B	$xx.xx	$250MM
	Carbon Robotics	--	--	$xx.xx	Series D	$365.73MM	$xx.xx	$64.2MM
	Farmer's Business Network	$7.07	-2.75%	$xx.xx	Series G	$3.89B	$xx.xx	$300MM
	Inari	--	--	$xx.xx	Series G	$2.17B	$xx.xx	$144MM
	Indigo Ag	--	--	$xx.xx	Series AA-1	$706.32MM	$xx.xx	$1.5MM
	Invaio	--	--	$xx.xx	--	--	--	--
	Manus Bio	--	--	$xx.xx	Series One	$258.84MM	$xx.xx	$32.5MM
	Plenty	--	--	$xx.xx	Series E	$1.25B	$xx.xx	$200MM
	Soli Organic	--	--	$xx.xx	--	--	--	--
	Ynsect	--	--	$xx.xx	--	--	--	--

See All Companies

Forge is your trusted partner to buy and sell Pivot Bio stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Feb 13, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Pivot Bio stock